Bruce L. Saltz
Albert Einstein College of Medicine
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Bruce L. Saltz.
Postgraduate Medicine | 2000
Bruce L. Saltz; Margaret G. Woerner; Delbert G. Robinson; John M. Kane
PREVIEW Clearly, the use of antipsychotic drugs can be extremely helpful in elderly patients to reduce psychotic symptoms and agitation. However, these drugs may produce serious side effects, such as parkinsonism, akathisia, dystonia, and tardive dyskinesia, that can range in intensity from mild to severe. In this article, the authors describe how to use antipsychotic agents in the most careful fashion possible.
Journal of Clinical Psychopharmacology | 1988
Jeffrey A. Lieberman; Michael Lesser; Celeste Johns; Simcha Pollack; Bruce L. Saltz; John M. Kane
Based on the results of two preliminary studies, we concluded that late-developing persistent drug-induced movement disorders are pharmacologically heterogeneous, and this heterogeneity is seen between individual patients (and groups of patients) as well as within body areas of individual patients; dystonic pathology has a distinct and more consistent response to pharmacologic stimulation than does nondystonic tardive dyskinesia (TD); and, although disturbances in dopamine and acetylcholine appear to be involved in these disorders, they do not in all cases exist in functionally opposite relationships. The observed pharmacologic heterogeneity in TD response reflects the limitations of the dopamine/acetylcholine model of TD, which oversimplifies the neuroanatomy of the basal ganglia and the pathophysiology of TD. The chemical and anatomical complexity of this region suggests that other neurotransmitter systems and neuronal circuits within and extending from the basal ganglia may be disturbed in the pathogenesis of TD.
Schizophrenia Research | 1993
Daniel Umbricht; Bruce L. Saltz; Simcha Pollack; Jefferey Lieberman
Dopamine supersensitivity, presumably playing a role in tardive dyskinesia, has been implicated in the unexplained polydipsia occurring in chronic psychiatric patients. To investigate this hypothesis, the authors compared laboratory measurements indicating the fluid status of 65 patients before and after the development of tardive dyskinesia. No evidence was found that patients who develop tardive dyskinesia concurrently develop abnormalities in fluid regulation.
British Journal of Psychiatry | 1991
Jeffrey A. Lieberman; Bruce L. Saltz; Celeste Johns; Simcha Pollack; Michael Borenstein; John M. Kane
American Journal of Psychiatry | 1998
Margaret G. Woerner; Jose Alvir; Bruce L. Saltz; Jeffrey A. Lieberman; John M. Kane
JAMA | 1991
Bruce L. Saltz; Margaret G. Woerner; John M. Kane; Jeffrey A. Lieberman; Jose Alvir; Kenneth J. Bergmann; Karen Blank; Jonathan Koblenzer; Kenneth Kahaner
American Journal of Psychiatry | 1993
Margaret G. Woerner; Bruce L. Saltz; John M. Kane; J. Lieberman; Alvir Jm
The Primary Care Companion To The Journal of Clinical Psychiatry | 2004
Bruce L. Saltz; Delbert G. Robinson; Margaret G. Woerner
Archive | 1996
Bruce L. Saltz; John Kane; Margaret G. Woerner; Jeffrey A. Lieberman; Alvir Jm
American Journal of Psychiatry | 1993
D. S. G. Umbricht; Bruce L. Saltz; Simcha Pollack; Margaret G. Woerner; John M. Kane; J. Lieberman